-
MindMed Q3 Earnings: Big Improvement, Kicks Off Sleep & Cognitive Study With Dose Low-Dose LSD
Tuesday, November 16, 2021 - 2:07pm | 481MindMed (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ), a biotech company developing psychedelic-inspired therapies, announced its financial results late Monday for the third quarter ended Sept. 30, 2021. Q3 & Nine Months 2021 Financial Highlights Total assets were $178.6 million, including $145.9...